Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol Dose to Suppress Intubation Response at High Altitude
ChiCTR2500109641Phase 2Not yet recruiting
- Sponsor
- People's Hospital of Changdu City
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of propofol in None, sponsored by People's Hospital of Changdu City. Primary endpoints: MOAA/S Assessment Scale, Blood pressure and 1 more. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
propofol
Beyond the preview
Go deeper on ChiCTR2500109641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109641.